Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Corinne Cather, Ph.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Diminich ED, Dickerson F, Bello I, Cather C, Kingdon D, Rakhshan Rouhakhtar PJ, Hart KL, Li C, Troxel AB, Goff DC. D-cycloserine augmentation of cognitive behavioral therapy for delusions: A randomized clinical trial. Schizophr Res. 2020 Jun 23. PMID: 32591238.
    Citations:    
  2. Browne J, Cather C, Zvonar V, Thayer K, Skiest H, Arntz D, Kritikos K, Schnitzer K, Brown H, Evins AE, Donovan A. Developing a Sound Body: Open Trial Results of a Group Healthy Lifestyle Intervention for Young Adults with Psychosis. Community Ment Health J. 2020 Jun 10. PMID: 32524260.
    Citations:    
  3. Daumit GL, Dalcin AT, Dickerson FB, Miller ER, Evins AE, Cather C, Jerome GJ, Young DR, Charleston JB, Gennusa JV, Goldsholl S, Cook C, Heller A, McGinty EE, Crum RM, Appel LJ, Wang NY. Effect of a Comprehensive Cardiovascular Risk Reduction Intervention in Persons With Serious Mental Illness: A Randomized Clinical Trial. JAMA Netw Open. 2020 Jun 01; 3(6):e207247. PMID: 32530472.
    Citations:    
  4. Turner DT, Reijnders M, van der Gaag M, Karyotaki E, Valmaggia LR, Moritz S, Lecomte T, Turkington D, Penadés R, Elkis H, Cather C, Shawyer F, O'Connor K, Li ZJ, de Paiva Barretto EM, Cuijpers P. Efficacy and Moderators of Cognitive Behavioural Therapy for Psychosis Versus Other Psychological Interventions: An Individual-Participant Data Meta-Analysis. Front Psychiatry. 2020; 11:402. PMID: 32431633.
    Citations:    
  5. Burke AS, Shapero BG, Pelletier-Baldelli A, Deng WY, Nyer MB, Leathem L, Namey L, Landa C, Cather C, Holt DJ. Rationale, Methods, Feasibility, and Preliminary Outcomes of a Transdiagnostic Prevention Program for At-Risk College Students. Front Psychiatry. 2019; 10:1030. PMID: 32158406.
    Citations:    
  6. Wright A, Browne J, Mueser KT, Cather C. Evidence-Based Psychosocial Treatment for Individuals with Early Psychosis. Child Adolesc Psychiatr Clin N Am. 2020 Jan; 29(1):211-223. PMID: 31708048.
    Citations:    
  7. Wright A, Cather C, Gilman J, Evins AE. The Changing Legal Landscape of Cannabis Use and Its Role in Youth-onset Psychosis. Child Adolesc Psychiatr Clin N Am. 2020 Jan; 29(1):145-156. PMID: 31708043.
    Citations:    
  8. Evins AE, Cather C, Daumit GL. Smoking cessation in people with serious mental illness. Lancet Psychiatry. 2019 07; 6(7):563-564. PMID: 30981756.
    Citations:    
  9. Dalcin AT, Jerome GJ, Appel LJ, Dickerson FB, Wang NY, Miller ER, Young DR, Charleston JB, Gennusa JV, Goldsholl S, Heller A, Evins AE, Cather C, McGinty EE, Crum RM, Daumit GL. Need for Cardiovascular Risk Reduction in Persons With Serious Mental Illness: Design of a Comprehensive Intervention. Front Psychiatry. 2018; 9:786. PMID: 30800079.
    Citations:    
  10. Otto MW, Pachas GN, Cather C, Hoeppner SS, Moshier SJ, Hearon BA, Ward HB, Laffer AB, Smits JAJ, Evins AE. A placebo-controlled randomized trial of D-cycloserine augmentation of cue exposure therapy for smoking cessation. Cogn Behav Ther. 2019 01; 48(1):65-76. PMID: 30111253.
    Citations:    Fields:    
  11. Schuster RM, Pachas GN, Stoeckel L, Cather C, Nadal M, Mischoulon D, Schoenfeld DA, Zhang H, Ulysse C, Dodds EB, Sobolewski S, Hudziak V, Hanly A, Fava M, Evins AE. Phase IIb Trial of an a7 Nicotinic Receptor Partial Agonist With and Without Nicotine Patch for Withdrawal-Associated Cognitive Deficits and Tobacco Abstinence. J Clin Psychopharmacol. 2018 Aug; 38(4):307-316. PMID: 29912798.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  12. Cather C, Brunette MF, Mueser KT, Babbin SF, Rosenheck R, Correll CU, Kalos-Meyer P. Impact of comprehensive treatment for first episode psychosis on substance use outcomes: A randomized controlled trial. Psychiatry Res. 2018 10; 268:303-311. PMID: 30086471.
    Citations:    Fields:    
  13. Cather C, Pachas GN, Cieslak KM, Evins AE. Achieving Smoking Cessation in Individuals with Schizophrenia: Special Considerations. CNS Drugs. 2017 Jun; 31(6):471-481. PMID: 28550660.
    Citations: 4     Fields:    Translation:Humans
  14. Cather C, Hoeppner S, Pachas G, Pratt S, Achtyes E, Cieslak KM, Evins AE. Improved Depressive Symptoms in Adults with Schizophrenia During a Smoking Cessation Attempt with Varenicline and Behavioral Therapy. J Dual Diagn. 2017 Jul-Sep; 13(3):168-178. PMID: 28414583.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  15. Schuster RM, Cather C, Pachas GN, Zhang H, Cieslak KM, Hoeppner SS, Schoenfeld D, Evins AE. Predictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy. Addict Behav. 2017 08; 71:89-95. PMID: 28285208.
    Citations: 1     Fields:    Translation:Humans
  16. Allen SI, Foulds J, Pachas GN, Veldheer S, Cather C, Azzouz N, Hrabovsky S, Hameed A, Yingst J, Hammett E, Modesto J, Krebs NM, Zhu J, Liao J, Muscat JE, Richie J, Evins AE. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol. BMC Public Health. 2017 01 19; 17(1):100. PMID: 28103841.
    Citations: 1     Fields:    Translation:HumansAnimals
  17. Evins AE, Hoeppner SS, Schoenfeld DA, Hoeppner BB, Cather C, Pachas GN, Cieslak KM, Maravic MC. Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder. Schizophr Res. 2017 05; 183:124-129. PMID: 27956009.
    Citations: 1     Fields:    Translation:Humans
  18. Thorndike AN, Achtyes ED, Cather C, Pratt S, Pachas GN, Hoeppner SS, Evins AE. Weight gain and 10-year cardiovascular risk with sustained tobacco abstinence in smokers with serious mental illness: a subgroup analysis of a randomized trial. J Clin Psychiatry. 2016 Mar; 77(3):e320-6. PMID: 27046320.
    Citations: 2     Fields:    Translation:Humans
  19. Evins AE, Cather C. Effective Cessation Strategies for Smokers with Schizophrenia. Int Rev Neurobiol. 2015; 124:133-47. PMID: 26472528.
    Citations: 3     Fields:    Translation:Humans
  20. Mueser KT, Penn DL, Addington J, Brunette MF, Gingerich S, Glynn SM, Lynde DW, Gottlieb JD, Meyer-Kalos P, McGurk SR, Cather C, Saade S, Robinson DG, Schooler NR, Rosenheck RA, Kane JM. The NAVIGATE Program for First-Episode Psychosis: Rationale, Overview, and Description of Psychosocial Components. Psychiatr Serv. 2015 Jul; 66(7):680-90. PMID: 25772766.
    Citations: 12     Fields:    Translation:Humans
  21. Evins AE, Cather C, Laffer A. Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices. Harv Rev Psychiatry. 2015 Mar-Apr; 23(2):90-8. PMID: 25747922.
    Citations: 10     Fields:    Translation:Humans
  22. Vincenzi B, Stock S, Borba CP, Cleary SM, Oppenheim CE, Petruzzi LJ, Fan X, Copeland PM, Freudenreich O, Cather C, Henderson DC. A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism. Schizophr Res. 2014 Nov; 159(2-3):395-403. PMID: 25261882.
    Citations: 5     Fields:    Translation:Humans
  23. Evins AE, Cather C, Pratt SA, Pachas GN, Hoeppner SS, Goff DC, Achtyes ED, Ayer D, Schoenfeld DA. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial. JAMA. 2014 Jan 08; 311(2):145-54. PMID: 24399553.
    Citations: 47     Fields:    Translation:Humans
  24. Greene DI, Spencer AE, Pridgen BC, Cather C, Ablon S. Evolving illness, shifting perspectives: childhood psychosis through the lenses of family therapy and individual therapy. Harv Rev Psychiatry. 2013 Sep-Oct; 21(5):259-68. PMID: 24651558.
    Citations:    Fields:    Translation:Humans
  25. Bartels SJ, Pratt SI, Mueser KT, Forester BP, Wolfe R, Cather C, Xie H, McHugo GJ, Bird B, Aschbrenner KA, Naslund JA, Feldman J. Long-term outcomes of a randomized trial of integrated skills training and preventive healthcare for older adults with serious mental illness. Am J Geriatr Psychiatry. 2014 Nov; 22(11):1251-61. PMID: 23954039.
    Citations: 19     Fields:    Translation:Humans
  26. Cather C, Dyer MA, Burrell HA, Hoeppner B, Goff DC, Evins AE. An Open Trial of Relapse Prevention Therapy for Smokers With Schizophrenia. J Dual Diagn. 2013; 9(1):87-93. PMID: 23750123.
    Citations: 8     Fields:    
  27. Pachas GN, Cather C, Pratt SA, Hoeppner B, Nino J, Carlini SV, Achtyes ED, Lando H, Mueser KT, Rigotti NA, Goff DC, Evins AE. Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial. J Dual Diagn. 2012; 8(2):117-125. PMID: 22888309.
    Citations: 17     Fields:    
  28. Gottlieb JD, Cather C, Shanahan M, Creedon T, Macklin EA, Goff DC. D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia. Schizophr Res. 2011 Sep; 131(1-3):69-74. PMID: 21723096.
    Citations: 21     Fields:    Translation:Humans
  29. Henderson DC, Freudenreich O, Borba CP, Wang X, Copeland PM, Macklin E, Fan X, Cather C, Goff DC. Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia. Schizophr Res. 2011 Aug; 130(1-3):53-6. PMID: 21565464.
    Citations: 4     Fields:    Translation:Humans
  30. Freudenreich O, Kontos N, Tranulis C, Cather C. Morgellons disease, or antipsychotic-responsive delusional parasitosis, in an HIV patient: beliefs in the age of the Internet. Psychosomatics. 2010 Nov-Dec; 51(6):453-7. PMID: 21051675.
    Citations: 3     Fields:    Translation:Humans
  31. Mueser KT, Pratt SI, Bartels SJ, Swain K, Forester B, Cather C, Feldman J. Randomized trial of social rehabilitation and integrated health care for older people with severe mental illness. J Consult Clin Psychol. 2010 Aug; 78(4):561-73. PMID: 20658812.
    Citations: 19     Fields:    Translation:Humans
  32. Mueser KT, Pratt SI, Bartels SJ, Forester B, Wolfe R, Cather C. Neurocognition and social skill in older persons with schizophrenia and major mood disorders: An analysis of gender and diagnosis effects. J Neurolinguistics. 2010 May; 23(3):297-317. PMID: 21113403.
    Citations: 11     
  33. Henderson DC, Sharma B, Fan X, Copeland PM, Borba CP, Freudenreich O, Cather C, Evins AE, Goff DC. Dietary saturated fat intake and glucose metabolism impairments in nondiabetic, nonobese patients with schizophrenia on clozapine or risperidone. Ann Clin Psychiatry. 2010 Feb; 22(1):33-42. PMID: 20196981.
    Citations: 5     Fields:    Translation:Humans
  34. Freudenreich O, Henderson DC, Macklin EA, Evins AE, Fan X, Cather C, Walsh JP, Goff DC. Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial. J Clin Psychiatry. 2009 Dec; 70(12):1674-80. PMID: 19689921.
    Citations: 14     Fields:    Translation:Humans
  35. Perivoliotis D, Cather C. Cognitive behavioral therapy of negative symptoms. J Clin Psychol. 2009 Aug; 65(8):815-30. PMID: 19572278.
    Citations: 4     Fields:    Translation:Humans
  36. Henderson DC, Fan X, Sharma B, Copeland PM, Borba CP, Freudenreich O, Cather C, Evins AE, Goff DC. Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine. J Psychiatr Pract. 2009 Jul; 15(4):251-61. PMID: 19625881.
    Citations: 3     Fields:    Translation:Humans
  37. Henderson DC, Fan X, Copeland PM, Sharma B, Borba CP, Boxill R, Freudenreich O, Cather C, Evins AE, Goff DC. Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients. J Clin Psychopharmacol. 2009 Apr; 29(2):165-9. PMID: 19512978.
    Citations: 10     Fields:    Translation:Humans
  38. Mueser KT, Glynn SM, Cather C, Zarate R, Fox L, Feldman J, Wolfe R, Clark RE. Family intervention for co-occurring substance use and severe psychiatric disorders: participant characteristics and correlates of initial engagement and more extended exposure in a randomized controlled trial. Addict Behav. 2009 Oct; 34(10):867-77. PMID: 19375870.
    Citations: 7     Fields:    Translation:Humans
  39. Otto MW, Basden SL, McHugh RK, Kantak KM, Deckersbach T, Cather C, Goff DC, Hofmann SG, Berry AC, Smits JA. Effects of D-cycloserine administration on weekly nonemotional memory tasks in healthy participants. Psychother Psychosom. 2009; 78(1):49-54. PMID: 19018157.
    Citations: 10     Fields:    Translation:Humans
  40. Culhane MA, Schoenfeld DA, Barr RS, Cather C, Deckersbach T, Freudenreich O, Goff DC, Rigotti NA, Evins AE. Predictors of early abstinence in smokers with schizophrenia. J Clin Psychiatry. 2008 Nov; 69(11):1743-50. PMID: 19026259.
    Citations: 17     Fields:    Translation:Humans
  41. Goff DC, Cather C, Gottlieb JD, Evins AE, Walsh J, Raeke L, Otto MW, Schoenfeld D, Green MF. Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study. Schizophr Res. 2008 Dec; 106(2-3):320-7. PMID: 18799288.
    Citations: 38     Fields:    Translation:Humans
  42. Goff DC, Cather C, Freudenreich O, Henderson DC, Evins AE, Culhane MA, Walsh JP. A placebo-controlled study of sildenafil effects on cognition in schizophrenia. Psychopharmacology (Berl). 2009 Jan; 202(1-3):411-7. PMID: 18716761.
    Citations: 14     Fields:    Translation:Humans
  43. Oliver Freudenreich, Constantin Tranulis, Cori Cather, David C. Henderson, A. Eden Evins, Donald C. Goff . Depressive Symptoms in Schizophrenia Outpatients—Prevalence and Clinical Correlates. Clinical Schizophrenia & Related Psychoses. 2008.
  44. Fan X, Henderson DC, Nguyen DD, Cather C, Freudenreich O, Evins AE, Borba CP, Goff DC. Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia. Psychiatry Res. 2008 May 30; 159(1-2):140-6. PMID: 18423611.
    Citations: 11     Fields:    Translation:Humans
  45. Freudenreich O, Holt DJ, Cather C, Goff DC. The evaluation and management of patients with first-episode schizophrenia: a selective, clinical review of diagnosis, treatment, and prognosis. Harv Rev Psychiatry. 2007 Sep-Oct; 15(5):189-211. PMID: 17924256.
    Citations: 4     Fields:    Translation:Humans
  46. Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. J Clin Psychopharmacol. 2007 Aug; 27(4):380-6. PMID: 17632223.
    Citations: 48     Fields:    Translation:Humans
  47. Fan X, Henderson DC, Chiang E, Briggs LB, Freudenreich O, Evins AE, Cather C, Goff DC. Sexual functioning, psychopathology and quality of life in patients with schizophrenia. Schizophr Res. 2007 Aug; 94(1-3):119-27. PMID: 17590315.
    Citations: 4     Fields:    Translation:Humans
  48. Henderson DC, Fan X, Copeland PM, Borba CP, Daley TB, Nguyen DD, Zhang H, Hayden D, Freudenreich O, Cather C, Evins AE, Goff DC. A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain. Acta Psychiatr Scand. 2007 Feb; 115(2):101-5. PMID: 17244173.
    Citations: 15     Fields:    Translation:Humans
  49. Cather C. Attention Training: A Novel Treatment Approach to Auditory Hallucinations. Cognitive and Behavioral Practice. 2007; 14(2):139-141.
  50. Freudenreich O, Cather C, Holt D. Stimulant misuse in college for "pseudo-attention deficit disorder" during schizophrenia prodrome. Am J Psychiatry. 2006 Nov; 163(11):2019. PMID: 17074965.
    Citations:    Fields:    Translation:Humans
  51. Henderson DC, Copeland PM, Borba CP, Daley TB, Nguyen DD, Cagliero E, Evins AE, Zhang H, Hayden DL, Freudenreich O, Cather C, Schoenfeld DA, Goff DC. Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis. J Clin Psychiatry. 2006 May; 67(5):789-97. PMID: 16841629.
    Citations: 12     Fields:    Translation:Humans
  52. Henderson DC, Borba CP, Daley TB, Boxill R, Nguyen DD, Culhane MA, Louie P, Cather C, Eden Evins A, Freudenreich O, Taber SM, Goff DC. Dietary intake profile of patients with schizophrenia. Ann Clin Psychiatry. 2006 Apr-Jun; 18(2):99-105. PMID: 16754415.
    Citations: 23     Fields:    Translation:Humans
  53. Holt DJ, Titone D, Long LS, Goff DC, Cather C, Rauch SL, Judge A, Kuperberg GR. The misattribution of salience in delusional patients with schizophrenia. Schizophr Res. 2006 Apr; 83(2-3):247-56. PMID: 16540291.
    Citations: 21     Fields:    Translation:Humans
  54. Henderson DC, Kunkel L, Nguyen DD, Borba CP, Daley TB, Louie PM, Freudenreich O, Cather C, Evins AE, Goff DC. An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia. Acta Psychiatr Scand. 2006 Feb; 113(2):142-7. PMID: 16423166.
    Citations: 22     Fields:    Translation:HumansCTClinical Trials
  55. Henderson DC, Copeland PM, Nguyen DD, Borba CP, Cather C, Eden Evins A, Freudenreich O, Baer L, Goff DC. Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophrenia. Acta Psychiatr Scand. 2006 Feb; 113(2):121-5. PMID: 16423163.
    Citations: 4     Fields:    Translation:Humans
  56. Couture SM, Roberts DL, Penn DL, Cather C, Otto MW, Goff D. Do baseline client characteristics predict the therapeutic alliance in the treatment of schizophrenia? J Nerv Ment Dis. 2006 Jan; 194(1):10-4. PMID: 16462549.
    Citations: 8     Fields:    Translation:Humans
  57. Freudenreich O, Herz L, Deckersbach T, Evins AE, Henderson DC, Cather C, Goff DC. Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial. Psychopharmacology (Berl). 2005 Sep; 181(2):358-63. PMID: 15778880.
    Citations: 20     Fields:    Translation:Humans
  58. Evins AE, Deckersbach T, Cather C, Freudenreich O, Culhane MA, Henderson DC, Green MF, Schoenfeld DA, Rigotti NA, Goff DC. Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. J Clin Psychiatry. 2005 Sep; 66(9):1184-90. PMID: 16187778.
    Citations: 17     Fields:    Translation:Humans
  59. Henderson DC, Nguyen DD, Copeland PM, Hayden DL, Borba CP, Louie PM, Freudenreich O, Evins AE, Cather C, Goff DC. Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study. J Clin Psychiatry. 2005 Sep; 66(9):1116-21. PMID: 16187768.
    Citations: 33     Fields:    Translation:Humans
  60. Evins AE, Cather C, Deckersbach T, Freudenreich O, Culhane MA, Olm-Shipman CM, Henderson DC, Schoenfeld DA, Goff DC, Rigotti NA. A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. J Clin Psychopharmacol. 2005 Jun; 25(3):218-25. PMID: 15876899.
    Citations: 52     Fields:    Translation:HumansCTClinical Trials
  61. O'Neil SE, Cather C, Fishel AK, Kafka M. "Not knowing if I was a pedophile ..."--diagnostic questions and treatment strategies in a case of OCD. Harv Rev Psychiatry. 2005 May-Jun; 13(3):186-96. PMID: 16020030.
    Citations:    Fields:    Translation:Humans
  62. Henderson DC, Copeland PM, Daley TB, Borba CP, Cather C, Nguyen DD, Louie PM, Evins AE, Freudenreich O, Hayden D, Goff DC. A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain. Am J Psychiatry. 2005 May; 162(5):954-62. PMID: 15863798.
    Citations: 23     Fields:    Translation:HumansCTClinical Trials
  63. Cather C, Penn D, Otto MW, Yovel I, Mueser KT, Goff DC. A pilot study of functional Cognitive Behavioral Therapy (fCBT) for schizophrenia. Schizophr Res. 2005 May 01; 74(2-3):201-9. PMID: 15722000.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  64. Cather C. Functional cognitive-behavioural therapy: a brief, individual treatment for functional impairments resulting from psychotic symptoms in schizophrenia. Canadian Journal of Psychiatry. 2005; 50(5):258-63.
  65. Cather C. Functional cognitive-behavioural therapy: a brief, individual treatment for functional impairments resulting from psychotic symptoms in schizophrenia. Can J Psychiatry. 2005 Apr; 50(5):258-63. PMID: 15968840.
    Citations: 2     Fields:    Translation:Humans
  66. Goff DC, Cather C, Evins AE, Henderson DC, Freudenreich O, Copeland PM, Bierer M, Duckworth K, Sacks FM. Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. J Clin Psychiatry. 2005 Feb; 66(2):183-94; quiz 147, 273-4. PMID: 15705003.
    Citations: 62     Fields:    Translation:HumansPHPublic Health
  67. Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. J Clin Psychiatry. 2004 Oct; 65(10):1372-6. PMID: 15491241.
    Citations: 29     Fields:    Translation:Humans
  68. Contrada RJ, Idler EL, Goyal TM, Cather C, Rafalson L, Krause TJ. Why not find out whether religious beliefs predict surgical outcomes? If they do, why not find out why? Reply to Freedland (2004). Health Psychol. 2004 May; 23(3):243-6. PMID: 15099164.
    Citations:    Fields:    Translation:Humans
  69. Contrada RJ, Goyal TM, Cather C, Rafalson L, Idler EL, Krause TJ. Psychosocial factors in outcomes of heart surgery: the impact of religious involvement and depressive symptoms. Health Psychol. 2004 May; 23(3):227-38. PMID: 15099162.
    Citations: 24     Fields:    Translation:Humans
  70. Evins AE, Cather C, Rigotti NA, Freudenreich O, Henderson DC, Olm-Shipman CM, Goff DC. Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction. J Clin Psychiatry. 2004 Mar; 65(3):307-11; quiz 452-3. PMID: 15096068.
    Citations: 24     Fields:    Translation:HumansCTClinical Trials
  71. Roberts DL, Penn DL, Cather C, Otto M & Goff DC. Should CBT target the social impairments associated with schizophrenia?. Journal of Cognitive Psychotherapy: An International Quarterly. 2004; 18:255-264.
  72. Cather C, Penn D, Otto MW, & Goff DC. Advances in the cognitive-behavioral treatment of schizophrenia: a focus on delusions. Journal of Cognitive Psychotherapy: An International Quarterly. 2004; 18:207-221.
  73. Penn DL, Mueser KT, Tarrier N, Gloege A, Cather C, Serrano D, Otto MW. Supportive therapy for schizophrenia: possible mechanisms and implications for adjunctive psychosocial treatments. Schizophr Bull. 2004; 30(1):101-12. PMID: 15176765.
    Citations: 16     Fields:    Translation:Humans
  74. Cather C, Goff DC, Mueser KT. Understanding and managing psychosis in the workplace. In: Langlieb A, Kahn JP editors. Mental health and productivity in the workplace. 2003.
  75. Evins AE, Mays VK, Rigotti NA, Tisdale T, Cather C, Goff DC. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine Tob Res. 2001 Nov; 3(4):397-403. PMID: 11694208.
    Citations: 42     Fields:    Translation:HumansCTClinical Trials
  76. Contrada RJ, Cather C, O’leary A. Personality and health. In: Pervin L editor. Handbook of personality: theory and research. 1999.
  77. Reed DR, Ding Y, Xu W, Cather C, Green ED, Price RA. Extreme obesity may be linked to markers flanking the human OB gene. Diabetes. 1996 May; 45(5):691-4. PMID: 8621025.
    Citations: 15     Fields:    Translation:HumansAnimalsCells
  78. Reed DR, Ding Y, Xu W, Cather C, Price RA. Human obesity does not segregate with the chromosomal regions of Prader-Willi, Bardet-Biedl, Cohen, Borjeson or Wilson-Turner syndromes. Int J Obes Relat Metab Disord. 1995 Sep; 19(9):599-603. PMID: 8574268.
    Citations: 6     Fields:    Translation:HumansCells
  79. Hamilton JC, Greenberg J, Pyszczynski T, Cather C. A self-regulatory perspective on psychopathology and psychotherapy. Journal of Psychotherapy Integration. 1993; 3:205-248.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Cather's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (285)
Explore
_
Co-Authors (42)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.